Global Blepharitis Market Growth (Status and Outlook) 2025-2031

The global Blepharitis market size is predicted to grow from US$ 1605 million in 2025 to US$ 2085 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.

Blepharitis is an inflammation of the eyelids in which they become red, irritated and itchy and dandruff-like scales form on the eyelashes. It is a common eye disorder caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. It affects people of all ages. Although uncomfortable, blepharitis is usually not contagious and generally does not cause any permanent damage to eyesight.

Market competition is intense. Bausch Health, Allergan, Novartis LABORATORIES THEA, etc. are the leaders of the industry. They hold key technologies and patents, with high-end customers, but only occupied 24.39% market share.

LPI (LP Information)' newest research report, the “Blepharitis Industry Forecast” looks at past sales and reviews total world Blepharitis sales in 2024, providing a comprehensive analysis by region and market sector of projected Blepharitis sales for 2025 through 2031. With Blepharitis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blepharitis industry.

This Insight Report provides a comprehensive analysis of the global Blepharitis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blepharitis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blepharitis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blepharitis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blepharitis.

This report presents a comprehensive overview, market shares, and growth opportunities of Blepharitis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Antibiotics
Steroids
Other

Segmentation by Application:
Monotherapy
Combination Drug Therapy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bausch Health
Allergan
Novartis
LABORATORIES THEA
Akorn
NovaBay Pharmaceuticals
Scope Ophthalmics

Please note: The report will take approximately 2 business days to prepare and deliver.